How to research a manufacturer across FDA names
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Medical-device intelligence
Research Theratest Laboratories, Inc. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.
This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.
22 clearance records and 0 recall records in the covered releases, across 1 source company names and 13 product codes. Dated history runs from Jan 14, 1991 to Mar 5, 2010.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| THERATEST EL-ANTI-CCP/2K090753 · NHX | Theratest Laboratories, Inc. | 510(k) | Mar 5, 2010FDA decision date |
| THERATEST EL-ANTI-TPO AND THERATEST EL-ANTI-THYROGLOBULIN, MODEL 104-119, 103-120K090760 · JZO | Theratest Laboratories, Inc. | 510(k) | Sep 3, 2009FDA decision date |
| THERATEST EL-TTG IGA/IGG AND THERATEST EL-GLIA IGA/IGG TEST SYSTEMSK071692 · MVM | Theratest Laboratories, Inc. | 510(k) | Nov 5, 2007FDA decision date |
| EL-ANCA: ANTI-MPO, ANTI-PR3, ANTI-MPO AND ANTI-PR3K061376 · MOB | Theratest Laboratories, Inc. | 510(k) | Jul 20, 2006FDA decision date |
| EL-ACL SCREEN; EL-ACL IGM, IGG, IGAK060176 · MID | Theratest Laboratories, Inc. | 510(k) | Feb 7, 2006FDA decision date |
| THERATEST EL-ANA PROFILESK051066 · LKP | Theratest Laboratories, Inc. | 510(k) | Oct 7, 2005FDA decision date |
| EL-ANA PROFILES: ANTI-CHROMATINK040291 · LJM | Theratest Laboratories, Inc. | 510(k) | Mar 11, 2004FDA decision date |
| THE THERATEST EL-ANA PROFILES: ANTI-CENTROMEREK024031 · LJM | Theratest Laboratories, Inc. | 510(k) | Feb 6, 2003FDA decision date |
| EL-ANA PROFILES: ANTI-RIBOSOMAL PROTEIN PK024151 · MQA | Theratest Laboratories, Inc. | 510(k) | Feb 6, 2003FDA decision date |
| EL-ANA PROFILES-2K1K002559 · LJM | Theratest Laboratories, Inc. | 510(k) | Sep 12, 2000FDA decision date |
| EL-ANA PROFILES: EL-ENA/4K982150 · LLL | Theratest Laboratories, Inc. | 510(k) | Aug 13, 1998FDA decision date |
| EL-ANA PROFILES: EL-ENA/5K982622 · LLL | Theratest Laboratories, Inc. | 510(k) | Aug 13, 1998FDA decision date |
| THE THERATEST EL-B2GP1 (IGM, IGG, IGA) AND EL-B2GP1SCRK972790 · MSV | Theratest Laboratories, Inc. | 510(k) | Dec 5, 1997FDA decision date |
| EL-B2GP1SCRK973882 · MSV | Theratest Laboratories, Inc. | 510(k) | Dec 5, 1997FDA decision date |
| THERATEST EL-RFSCRK962050 · DHR | Theratest Laboratories, Inc. | 510(k) | Dec 16, 1996FDA decision date |
| THERATEST KIT (MODIFICATION)K955481 · LJM | Theratest Laboratories, Inc. | 510(k) | Mar 6, 1996FDA decision date |
| THERATEST LAB, INC., EL-ANASCR KITK954106 · LJM | Theratest Laboratories, Inc. | 510(k) | Nov 14, 1995FDA decision date |
| THERATEST EL-ANA PROFILES TEST SYSTEMK950716 · LJM | Theratest Laboratories, Inc. | 510(k) | Sep 26, 1995FDA decision date |
| EL-RF/3 (IGM-IGG-IGA) KITK941398 · DHR | Theratest Laboratories, Inc. | 510(k) | Jul 28, 1995FDA decision date |
| EL-RF TEST SYSTEM: EL-RF-IGM KITK933712 · DHR | Theratest Laboratories, Inc. | 510(k) | Jan 28, 1994FDA decision date |
| THE THERATEST EL-ANA PROFILESK914454 · LKJ | Theratest Laboratories, Inc. | 510(k) | May 22, 1992FDA decision date |
| THE THERATEST ACA TESTK905301 · GFO | Theratest Laboratories, Inc. | 510(k) | Jan 14, 1991FDA decision date |
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Build a repeatable clearance search using FDA applicant names, product codes, decision dates, and original records.
Read the guide →FDA dataset:
Last successful check: Nov 22, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.